Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam

Acta Psychiatrica Scandinavica

Volumn 78, Issue 3, 1988, Pages 396-398

  Kontaxakis, V P ^a   Christodoulou, G N ^a   Markidis, M P ^a   Havaki Kontaxaki B J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

depot neuroleptic; diazepam; NMS; schizophrenia

Indexed keywords

DIAZEPAM; FLUPHENAZINE DECANOATE;

ADULT; CASE REPORT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA;

ADMINISTRATION, ORAL; ADULT; CASE REPORT; DIAZEPAM; DRUG THERAPY, COMBINATION; FLUPHENAZINE; HUMAN; INJECTIONS, INTRAMUSCULAR; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA, PARANOID;

EID: 0023729033     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1988.tb06355.x     Document Type: Article

References (16)

1. The neuroleptic malignant syndrome
2. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
3. Neuroleptic malignant syndrome: review and analysis of 115 cases
4. Neuroleptic malignant syndrome
5. The neuroleptic malignant syndrome, so‐called. A survey of the world literature
6. Neuroleptic malignant syndrome (editorial)
7. Neuroleptic malignant syndrome: the pendulum swings (editorial)
8. Diagnosing and treating neuroleptic malignant syndrome
9. Mean serum creatine kinase activity in patients with functional psychoses
10. Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia
11. Neuroleptic malignant syndrome
12. Chloropromazine‐induced neuroleptic malignant syndrome and its response to diazepam
13. Intravenous lorazepam in neuroleptic‐induced catatonia
14. Lorazepam for psychogenic catatonia
15. Neuroleptic catatonia and its relationship to psychogenic catatonia